Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium

Anesthesiology

Volumn 92, Issue 3, 2000, Pages 821-832

  Kindler, Christoph H ^a   Verotta, Davide ^b   Gray, Andrew T ^b   Gropper, Michael A ^b   Yost, C Spencer ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Antagonists; Corticosteroids; Drug interaction; Intensive care; Paralysis; Vecuronium

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; METHYLPREDNISOLONE; NEUROMUSCULAR BLOCKING AGENT; NICOTINIC RECEPTOR; VECURONIUM;

ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PARALYSIS; PRIORITY JOURNAL;

EID: 0034093579     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200003000-00026     Document Type: Article

References (45)

1. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ: Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47:1223-31
2. Zifko UA, Zipko HT, Bolton CF: Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 1998; 159: 186-93
3. Hirano M, Ott BR, Raps EC, Minetti C, Lennihan L, Libbey NP, Bonilla E, Hays AP: Acute quadriplegic myopathy: A complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992; 42:2082-7
4. Fischer JR, Baer RK: Acute myopathy associated with combined use of corticosteroids and neuromuscular blocking agents. Ann Pharmacother 1996; 30:1437-45
5. MacFarlane IA, Rosenthal FD: Severe myopathy after status asthmaticus [letter]. Lancet 1977; 2:615
6. Kaplan PW, Rocha W, Sanders DB, D'Souza B, Spock A: Acute steroid-induced tetraplegia following status asthmaticus. Pediatrics 1986; 78:121-3
7. Douglass JA, Tuxen DV, Home M, Scheinkestel CD, Weinmann M, Czarny D, Bowes G: Myopathy in severe asthma. Am Rev Respir Dis 1992; 146:517-9
8. Griffin D, Fairman N, Coursin D, Rawsthorne L, Grossman JE: Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992; 102:510-4
9. Dodson BA, Kelly BJ, Braswell LM, Cohen NH: Changes in acetylcholine receptor number in muscle from critically ill patients receiving muscle relaxants: An investigation of the molecular mechanism of prolonged paralysis. Crit Care Med 1995; 23:815-21
10. Gooch JL, Suchyta MR, Balbierz JM, Petajan JH, Clemmer TP: Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991; 19:1125-31
11. Unwin N: Nicotinic acetylcholine receptor at 9 A resolution. J Mol Biol 1993; 229:1101-24
12. Mishina M, Takai T, Imoto K, Noda M, Takahashi T, Numa S, Methfessel C, Sakmann B: Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 1986; 321:406-11
13. Sine SM, Claudio T, Sigworth FJ: Activation of Torpedo acetylcholine receptors expressed in mouse fibroblasts. Single channel current kinetics reveal distinct agonist binding affinities. J Gen Physiol 1990; 96:395-437
14. Kurosaki T, Fukuda K, Konno T, Mori Y, Tanaka K, Mishina M, Numa S: Functional properties of nicotinic acetylcholine receptor subunits expressed in various combinations. FEBS Lett 1987; 214:253-8
15. Sine SM, Claudio T: Gamma- and delta-subunits regulate the affinity and the cooperativity of ligand binding to the acetylcholine receptor. J Biol Chem 1991; 266:19369-77
16. Sine SM: Molecular dissection of subunit interfaces in the acetylcholine receptor: Identification of residues that determine curare selectivity. Proc Natl Acad Sci 1993; 90:9436-40
17. Sine SM, Taylor P: Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem 1981; 256:6692-9
18. Sine SM, Taylor P: Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. J Biol Chem 1982; 257:8106-14
19. Heidmann T, Oswald RE, Changeux J-P: Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from Torpedo marmorata. Biochemistry 1983; 22:3112-27
20. Arias HR: Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor. Mol Membr Biol 1996; 13:1-17
21. Valera S, Ballivet M, Bertrand D: Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci 1992; 89:9949-53
22. Ke L, Lukas RJ: Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor sub-types. J Neurochem 1996; 67:1100-12
23. Bouzat C, Barrantes FJ: Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone. Possible allosteric mechanism of channel blockade. J Biol Chem 1996; 271:25835-41
24. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 1984; 12:7035-56
25. Quick MW, Lester HA: Methods for expression of excitability proteins in Xenopus oocytes, Methods in Neuroscience. Edited by Conn PM. San Diego, Academic Press, 1994, pp 261-79
26. Dascal N: The use of Xenopus oocytes for the study of ion channels. Crit Rev Biochem 1987; 22:317-87
27. Bradley RJ, Sterz R, Peper K: The effects of alcohols and diols at the nicotinic acetylcholine receptor of the neuromuscular junction. Brain Res 1984; 295:101-12
28. Dodson BA, Braswell LM, Miller KW: Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes. Mol Pharm 1987; 32:119-26
29. Akaike H: A new look at the statistical model identification. IEEE T Automat Contr 1974; 19:716-23
30. Labarca C, Nowak MW, Zhang H, Tang L, Deshpande P, Lester HA: Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors. Nature 1995; 376: 514-6
31. Kuffler SW, Yoshikami D: The number of transmitter molecules in a quantum: An estimate from iontophoretic application of acetylcholine at the neuromuscular synapse. J Physiol 1975; 251:465-82
32. Wray D: Prolonged exposure to acetylcholine: Noise analysis and channel inactivation in cat tenuissimus muscle. J Physiol 1981; 310:37-56
33. Defer GL, Barre J, Ledudal P, Tillement JP, Degos JD: Methylprednisolone infusion during acute exacerbation of MS: Plasma and CSF concentrations. Eur Neurol 1995; 35:143-8
34. Bouzat C, Barrantes FJ: Hydrocortisone and 11-desoxycortisone modify acetylcholine receptor channel gating. Neuroreport 1993; 4:143-6
35. Carlson GL, Saeed M, Little RA, Irving MH: Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis. Am J Physiol 1999; 276:E658-62
36. Veldsema-Currie RD, Wolters E, Leeuwin RS: The effect of corticosteroids and hemicholinium-3 on choline uptake and incorporation into acetylcholine in rat diaphragm. Eur J Pharmacol 1976; 35:399-402
37. Yost CS, Winegar BD: Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors. Cell Mol Neurobiol 1997; 17:35-50
38. Fletcher GH, Steinbach JH: Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors. Mol Pharmacol 1996; 49:938-47
39. Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL: Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994; 17:647-54
40. Sigg DC, Hasinoff IK, laizzo PA: Weakness in the intensive care unit: Differential diagnosis, Progress in Anesthesiology, vol XII. Edited by Eisenkraft JB. San Antonio, Dannemiller Memorial Education Foundation, 1998, pp 127-52
41. Nava S, Gayan-Ramirez G, Rollier H, Bisschop A, Dom R, de Bock V, Decramer M: Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am J Respir Crit Care Med 1996; 153:1888-96
42. Rouleau G, Karpati G, Carpenter S, Soza M, Prescott S, Holland P: Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 1987; 10:428-38
43. Wokke JH, Jennekens FG, van den Oord CJ, Veldman H, van Gijn J: Histological investigations of muscle atrophy and end plates in two critically ill patients with generalized weakness. J Neurol Sci 1988; 88:95-106
44. DuBois DC, Almon RR: A possible role for glucocorticoids in denervation atrophy. Muscle Nerve 1981; 4:370-3
45. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD: Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327:524-8